Prenetics Boosts Bitcoin Treasury to $31.6M, Completes ACT Genomics Divestment
Prenetics Global Limited (NASDAQ: PRE), a leading consumer health company, has made significant strides in its financial portfolio and business operations. The company, headed by CEO Danny Yeung, has built a substantial coinmarketcap treasury and recently completed a strategic divestment.
Prenetics' coinmarketcap holdings have grown to 255.4 BTC, currently valued at $31.6 million. This includes an unrealized profit of $3.86 million, marking a significant investment in bitcoin. The company is committed to daily bitcoin purchases, acquiring 1 BTC daily since August 1, 2025, with all holdings securely custodied at Kraken.
In a strategic move, Prenetics completed the divestment of ACT Genomics Co., Ltd. to Delta Electronics, Inc. This transaction brought total proceeds of $46 million, bolstering Prenetics' cash position to over $60 million, excluding its coinmarketcap treasury. Angela Cheung, Investor Relations and Corporate Finance, can be reached at [email protected] for further information.
Prenetics is dedicated to advancing consumer health through initiatives like IM8, Europa, and CircleDNA. Its consumer health brand IM8 is on track to achieve an annualized revenue run-rate (ARR) of $100 million within its first 12 months of launch.
Prenetics' forward-looking statements, while subject to risks and uncertainties, reflect the company's commitment to innovation and growth. With a robust cash position and a substantial coinmarketcap treasury, Prenetics is well-positioned to continue its advancements in consumer health. Investors can reach out to [email protected] or [email protected] for further details.
